The Hill may be compensated and/or receive an affiliate commission if you buy through our links. Events of the past year or so have challenged our collective mental health in ways we never could have ...
The Fisher Wallace cranial electrotherapy stimulation device. (Fisher Wallace Photo) Editor’s note: The story has been updated to correct its description of the study’s purpose. The study is testing ...
NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- Fisher Wallace Laboratories, the market leader in prescription wearable technology for the treatment of neuropsychiatric disorders, announces today the ...
The February advisory committee hearing for cranial electrotherapy stimulator (CES) devices was chock full of controversy during the course of the hearing, but one of the companies with an offering in ...